Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LVNG RX vs PrideRx

LVNG RX
Graded #268

Higher grade

vs+6.799999999999997
PrideRx
Graded #434

Lower grade

The verdict

LVNG RX takes it — 62.5/100 to 55.7/100.

LVNG RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LVNG RX is a Delaware-registered telehealth platform (LVNG RX LLC) offering compounded semaglutide from $149/mo and tirzepatide from $249/mo, plus a lower-dose GLP-1 microdose program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLVNG RX +44
64
20
Dose & formulationPrideRx +19
64
83
Clinical oversightPrideRx +18
56
74
Labs & monitoringLVNG RX +9
62
53
FulfillmentLVNG RX +2
69
67
Contract termsLVNG RX +20
61
41
LVNG RX · left barPrideRx · right bar

The numbers

MetricLVNG RXPrideRx
WeighScore62.5/10055.7/100
GradeCC
Scorecard rank#268#434
Semaglutide$149/mo (starting dose, compounded)$149/mo (starting dose, plus a separate fee, brand-name)
Tirzepatide$249/mo (microdose tier, starting dose, compounded)$299/mo (2.5 mg dose, plus a separate fee, brand-name)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
LVNG RX

Graded #268 · C

Strengths

  • One bundled price covers the provider visit, prescription, shipping and ongoing check-ins, with zero consultation charges
  • States you are charged nothing if a provider does not approve you for treatment
  • Promises no dose-change surcharges — 'the price we quote is the price you pay, period'
  • Semaglutide from $149/mo is competitive against the wider compounded market
  • Offers a lower-dose GLP-1 microdose program alongside standard semaglutide and tirzepatide

Where it loses points

  • Displays a Trustpilot 'Rated Excellent 4.8 / 5' badge, but no Trustpilot profile exists for the domain or the brand
  • Also claims '4.9 based on 300+ Google reviews'; no Google listing for the business could be located
  • Its own homepage figures conflict — '10k+' members in the hero versus '1,743+ patients supported' in the counters below
  • The actual plan price is confirmed only after provider review, and the three treatment pages publish no prices at all
  • No compounding pharmacy, medical group or individual clinician is named anywhere on the site
PrideRx

Graded #434 · C

Strengths

  • All three brand-name GLP-1 options on one platform — Zepbound injection, Wegovy Pill, and Foundayo — no compounded substitutes
  • Medication ships from and is billed by LillyDirect or NovoCare; PrideRx never handles or re-sells the drug
  • Transparent published per-dose pricing with on-page verification dates
  • $99/mo membership includes doctor visits and prescription management; 24-hour prescription review

Where it loses points

  • $99/mo membership on top of medication cost — all-in runs $248–$548/mo depending on drug and dose
  • Legal entity and prescribing medical group are not named on the site
  • No LegitScript certification visible
  • State availability is not published — telehealth consult rules vary by state

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard